Evidence for a T-lymphocyte dependent mechanism involving proinflammatory cytokines in anticonvulsant hypersensitivity syndrome: A case report.

被引:23
作者
Chiappini, E [1 ]
Peruzzi, M [1 ]
Galli, L [1 ]
Calabri, G [1 ]
de Martino, M [1 ]
机构
[1] Univ Florence, Anna Meyer Childrens Hosp, Dept Paediat, Div Paediat & Infect Dis, I-50132 Florence, Italy
关键词
anticonvulsant hypersensitivity syndrome; phenobarbital; interleukin-6; T-lymphocytes;
D O I
10.1177/039463200201500311
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The anticonvulsant drug hypersensitivity syndrome (AHS) is a potentially fatal drug reaction associated with aromatic antiepileptic drugs, the pathogenic mechanisms of which are still unclear. We studied a 2-year-old female affected with AHS after phenobarbital treatment. In vitro experiments showed a T-lymphocyte response to the drug and an increased, dose-related, IL-6 production after drug incubation. These findings suggest that AHS may be caused by a T-lymphocyte dependent mechanism, involving pro-inflammatory cytokines.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 16 条
[1]  
Antonen J, 1999, J RHEUMATOL, V26, P2585
[2]  
Belli F, 2000, INT J IMMUNOPATH PH, V13, P61
[3]  
Benoni G, 2001, INT J IMMUNOPATH PH, V14, P161
[4]   Drug-induced hypersensitivity syndrome in pediatric patients [J].
Carroll, MC ;
Yueng-Yue, NB ;
Esterly, NB ;
Drolet, BA .
PEDIATRICS, 2001, 108 (02) :485-493
[5]   Drug allergy diagnosis in humans: possibilities and pitfalls [J].
Choquet-Kastylevsky, G ;
Vial, T ;
Descotes, J .
TOXICOLOGY, 2001, 158 (1-2) :1-10
[6]   Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock [J].
Dinarello, CA .
CHEST, 1997, 112 (06) :321S-329S
[7]   Proinflammatory cytokines [J].
Dinarello, CA .
CHEST, 2000, 118 (02) :503-508
[8]   Extrapolation of experimental safety data to humans: The interleukin-6 case [J].
Kammuller, M ;
Ryffel, B .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 83 (01) :15-17
[9]  
Kasahara S, 2001, INT J IMMUNOPATH PH, V14, P63
[10]   Anticonvulsant hypersensitivity syndrome - Incidence, prevention and management [J].
Knowles, SR ;
Shapiro, LE ;
Shear, NH .
DRUG SAFETY, 1999, 21 (06) :489-501